Monday, 10 May 2021
COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India
To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year
from Top Business News- News18.com
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year
No comments:
Post a Comment